Immunosuppression

Latest research

1. Duale Inhibition bei HS und Psoriasis

   • Martha-Luise Storre

   in ästhetische dermatologie & kosmetologie

   Article 20 October 2025

2. Mit IL-31-Hemmung gegen Juckreiz

   • Friederike Klein

   in ästhetische dermatologie & kosmetologie

   Article 20 October 2025

3. Stammzelltransplantation verhindert schubunabhängige Progression

   • Thomas Müller

   in InFo Neurologie + Psychiatrie

   Article 20 October 2025

4. Rituximab

   in Reactions Weekly

   Article 18 October 2025

5. Multiple drugs

   in Reactions Weekly

   Article 18 October 2025

6. Comment on “immunosuppressive therapy management during sepsis in kidney transplant recipients: a prospective multicenter study”

   • Shuo Lin
   • Jianjie Ju
   • Zhouhua Wang

   in Annals of Intensive Care

   Article Open access 18 October 2025

7. Hilotherapie

   • Trudi Schaper
   • Athina Kostara

   in gynäkologie + geburtshilfe

   Article 17 October 2025

8. „Zum Haareraufen“: Alopezie

   • Liesl Häussermann-Mangold

   in gynäkologie + geburtshilfe

   Article 17 October 2025

   

9. Potential benefit of anticoagulation in Behçet syndrome

   • Serhat Erol
   • Aslıhan Gürün Kaya
   • Turan Acıcan

   in Nature Reviews Rheumatology

   Article 16 October 2025

10. Anti-inflammatories, azathioprine

    in Reactions Weekly

    Article 11 October 2025

11. Shield or risk immunosuppressant choice and Pneumocystis pneumonia after kidney transplant

    • Dua Jabbar
    • Noor un nisa Irshad
    • Prem Chand

    in International Urology and Nephrology

    Article 11 October 2025

12. Infliximab

    in Reactions Weekly

    Article 11 October 2025

13. SLE: Dapirolizumab Pegol als potenzielle neue Therapieoption

    • Redaktion Facharztmagazine

    in Orthopädie & Rheuma

    Article 07 October 2025

14. Investigation of adherence to immunosuppressive therapy and perceived social support in organ recipients

    • Satı Doğan
    • Özkan Uğuz
    • Müjgan Solak

    in European Journal of Medical Research

    Article Open access 04 October 2025

    

15. Effects of infliximab, an anti-TNF-α, on cyclophosphamide-induced bone marrow toxicity

    • Koorosh Tabatabaei
    • Haleh Vaez
    • Behrooz Shokouhi

    in Cancer Chemotherapy and Pharmacology

    Article 03 October 2025

    

16. Ocrelizumab jetzt auch für die Stillzeit zugelassenr

    • Redaktion Facharztmagazine

    in DNP – Die Neurologie & Psychiatrie

    Article 01 October 2025

17. Cytomegalovirus infection contributes to acute rejection in solid organ transplant recipients: a systematic review and meta-analysis

    • Amirreza Keyvanfar
    • Shabnam Tehrani
    • Hanieh Najafiarab

    in BMC Infectious Diseases

    Article Open access 29 September 2025

    

18. Disseminated nocardiosis involving lung, liver, and spleen in a patient with intestinal Behçet’s disease under combined immunosuppressive therapy

    • Tomohiro Betto
    • Risako Sudo
    • Chika Kusano

    in Clinical Journal of Gastroenterology

    Article 27 September 2025

    

19. Ryzneuta® - erster PEG-freier G-CSF

    • Günter Springer

    in MMW - Fortschritte der Medizin

    Article 26 September 2025

20. Neuer FcRn-Blocker mit Potenzial bei Myasthenia gravis

    • Jennifer Strohhäcker

    in InFo Neurologie + Psychiatrie

    Article 26 September 2025

Related journals

• 

  Journal

  Reactions Weekly

  Reactions Weeklyis the unique one-stop-shop for all your adverse drug event needs, bringing you up-to-the minute summaries of the world's adverse...

  Publishing model

  Subscription

  Downloads

  904,085 (2024)

• 

  Journal

  hautnah dermatologie

  Die Zeitschrift bietet anschauliche und praxisnahe Fortbildung aus dem breiten Berufsfeld der dermatologisch tätigen Ärzte. Schwerpunkte sind...

  Publishing model

  Subscription

  Downloads

  485,258 (2024)

• 

  Journal

  Journal of Clinical Immunology

  The Journal of Clinical Immunologypublishes high impact papers in the area of human immunology that explore the diagnosis, pathogenesis, prognosis,...

  Publishing model

  Open Access

  Journal Impact Factor

  5.7 (2024)

  Downloads

  954,431 (2024)

  Submission to first decision(median)

  3 days